Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL
Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL
Recruiting · NCT06886074 · Registry updated 2025-03-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL | Hemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2025-03-20 | NCT06886074 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospital Universitario Dr. Jose E. Gonzalez | 12 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Universitario Dr. Jose E. Gonzalez | Monterrey | Mexico | 3 |